Showing results (31-40 of 683) with videos related to
Sort By:
Pageof 69
Scandinavian Journal of Immunology|January 1, 1977
Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amidesK BendtzenActa Allergologica|December 1, 1975
Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucoseK BendtzenJournal of Immunological Methods|January 1, 1976
Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophorsisK BendtzenScandinavian Journal of Immunology|January 1, 1980
Differential role of Zn2+ in antigen- and mitogen-induced lymphokine productionK BendtzenBiochimica Et Biophysica Acta|January 12, 1979
Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMPK BendtzenScandinavian Journal of Immunology|January 1, 1979
Substrate specificity of the human lymphokine leucocyte migration-inhibitory factor (LIF): radioenzymic assay and inhibition by cGMPK BendtzenScandinavian Journal of Immunology|January 1, 1977
Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokineK BendtzenJournal of Immunological Methods|January 1, 1976
Affinity chromatography. A new technique for partial purification of human leucocyte migration inhibitory factorK BendtzenScandinavian Journal of Immunology|January 1, 1977
Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitorsK BendtzenScandinavian Journal of Immunology|January 1, 1977
Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluorideK BendtzenPageof 69